Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Xenoport Inc (NASDAQ:XNPT)

3.86
Delayed Data
As of 4:00pm ET
 -0.10 / -2.53%
Today’s Change
3.35
Today|||52-Week Range
8.67
-29.69%
Year-to-Date
No recent news for Xenoport Inc.

Today’s Trading

Previous close3.96
Today’s open3.83
Day’s range3.70 - 4.06
Volume8,343,261
Average volume (3 months)1,403,501
Market cap$250.3M
Dividend yield--
Data as of 4:00pm ET, 02/11/2016

Growth & Valuation

Earnings growth (last year)+55.25%
Earnings growth (this year)-69.19%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+489.46%
P/E ratioNM
Price/Sales11.39
Price/Book2.71

Competitors

 Today’s
change
Today’s
% change
VSARVersartis Inc-0.68-7.86%
OREXOrexigen Therapeutic...0.000.00%
CHMAChiasma Inc+0.05+0.50%
VTLVital Therapies Inc-0.33-4.22%
Data as of 4:00pm ET, 02/11/2016

Financials

Next reporting dateFebruary 18, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$46.9M
Annual profit (last year)-$49.3M
Net profit margin-105.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Vincent J. Angotti
Chief Financial Officer &
Senior VP-Finance
William G. Harris
Corporate headquarters
Santa Clara, California

Forecasts

Partner Offers